A Remote, Decentralized Opioid Use Disorder Study to Evaluate Patient Engagement With a Game-Based Digital Therapeutic
Completed · Not applicable
Conditions studied: Opioid-use Disorder
In brief
The purpose of this study is to evaluate how patients use and engage with a game-based mobile application that is designed to treat opioid use disorder.
Key facts
- Study ID
- NCT04542642
- Run by
- Pear Therapeutics, Inc.
- People needed
- 52
- Starts
- 2021-05-19
- Expected to finish
- 2022-11-23
- Last updated by the study team
- 2022-12-14
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Provide informed consent prior to any study specific assessments being performed
- Between 18 and 60 years old, inclusively
- Proficient in English language
- Within the first 120 days of starting buprenorphine treatment
- Receiving buprenorphine pharmacotherapy under the care of a licensed healthcare provider and willing to provide the provider or practice name
- Capable of using common software applications on a mobile device (smartphone)
- Access to an internet-enabled smartphone for the duration of the study, meeting minimal operations systems (OS) requirements
- Interest in using a digital therapeutic for Opioid-use Disorder
- No prior history of reSET-O use
- Has not participated in user testing of PEAR-008 or any investigational drug trials within the past 30 days of enrollment
You may not qualify if…
- On methadone or naltrexone pharmacotherapy
- Unable to use English to participate in the consent process, interventions, or assessments
- Inability to comply with study procedures
Where it is running
- The Substance and Treatment Research Service (STARS) at Columbia University Irving Medical Center and the New York State Psychiatric Institute — New York, New York, United States
- Addiction Research and Education Foundation — Gig Harbor, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.